CD276 and breast cancer: Given B7H3’s role in the immune evasion of breast cancer, it is hypothesized that hsa-miR-214-3p could suppress breast cancer cell proliferation and enhance immune cell activity by modulating B7H3 expression, thereby influencing BRCA development.